Microdosing Cautions and Corporate Exploitation

This chapter highlights the need for caution when exploring microdosing treatments, especially in relation to autoimmune diseases and addiction. It underscores the importance of responsible use, ethical considerations surrounding pharmaceutical practices, and the necessity of FDA approval for therapeutic interventions.